Steven Cohen Doubles The S&P 500 — And His Next Bet's All Gut

Steven Cohen's Point72 Asset Management just pulled off what most fund managers only dream of — doubling the S&P 500's three-year return — and he's still not easing up. The billionaire investor's next move? A fresh swing into biotech, backing Palisade Bio Inc (NASDAQ:PALI) — a tiny, high-volatility stock working on gut-health therapies that's suddenly caught Wall Street's attention.Track PALI stock here.A Hedge Fund That Hits For PowerThe top 20 holdings in Point72's Q2 filing have surged 131% cumulatively ...